A pharmacovigilance study of olanzapine/samidorphan based on FDA Adverse Event Reporting System (FAERS)

Authors

Institutions

Publication Details

Journal
BMC Pharmacology and Toxicology
Published
2025-02-20
DOI
https://doi.org/10.1186/s40360-025-00869-4
Citations
2
Primary Topic
Pharmacovigilance and Adverse Drug Reactions
Type
article
Field-Weighted Citation Impact
2.61

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A pharmacovigilance study of olanzapine/samidorphan based on FDA Adverse Event Reporting System (FAERS)

Luyao He, Lei Zhang, Li Y, Hongfei Li et al.
2 citations
BMC Pharmacology and Toxicology
Pharmacovigilance and Adverse Drug Reactions
2.61
article

A pharmacovigilance study of olanzapine/samidorphan based on FDA Adverse Event Reporting System (FAERS)

Luyao He, Lei Zhang, Li Y, Hongfei Li, Mengting Shen
article en
2 citations

Abstract

No abstract available for this paper.
BMC Pharmacology and ToxicologyVol. 26(1)
Shanghai Jiao Tong University (CN), Shanghai Mental Health Center (CN), Shanghai Clinical Research Center (CN)
Shanghai Municipal Health Commission, Shanghai Clinical Research Center, Shanghai Clinical Research Center for Mental Health, Fundamental Research Funds for the Central Universities
Openalex Percentile: Top 14%
Pharmacovigilance and Adverse Drug Reactions
2.61
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.